EverGlade Insights Blog

BARDA Issues Amendment 3 to BAA for Medical Countermeasures R&D

The Biomedical Advanced Research and Development Authority (BARDA) has recently unveiled significant updates to its Broad Agency Announcement (BAA), emphasizing a more refined and responsive approach to public health preparedness. Amendment 3, in particular, brings...

A Comprehensive Guide to ARPA-H Funding: Process, Financial, and Technical Requirements

The Advanced Research Projects Agency for Health (ARPA-H) stands as a beacon for those within the biomedical and health sectors, propelling transformative research initiatives and breakthroughs. The pursuit of funding from ARPA-H is a monumental...

EverGlade Consulting Lands ModeX Therapeutics Up to $168 Million in BARDA Funding

EverGlade Consulting, a national consulting firm, has helped ModeX Therapeutics successfully secure up to $168 million in funding through a contract with the Biomedical Advanced Research and Development Authority (“BARDA”) to develop novel multispecific antibodies...

ARPA-H Solicits Proposals For REACT Program

Advanced Research Projects Agency (ARPA-H) Solicits Proposals for Resilient Extended Automatic Cell Therapies (REACT) Program The Advanced Research Projects Agency for Health (ARPA-H) is actively seeking innovative proposals through the Resilient Extended Automatic Cell Therapies...

Effective Post-Award Management of a BARDA Contract

The Biomedical Advanced Research and Development Authority (BARDA) plays a pivotal role in the United States’ preparedness for public health emergencies. BARDA contracts support the development, procurement, and deployment of medical countermeasures critical for safeguarding...

Guide to BARDA Funding Broad Agency Announcement Update

The Biomedical Advanced Research and Development Authority (BARDA), a USG agency that operates within the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS),...